- Free worldwide shipping, tracked and insured
- Same day dispatch, customs handled
- Certificate of analysis for every batch
- Three-component tissue-repair research in a single vial
- Combined angiogenesis and cell-migration pathway studies
- Tissue-remodeling and collagen research (GHK-Cu component)
Overview
What is GLOW Blend?
The GLOW blend is a research compound combining three peptides (TB-500, BPC-157, and GHK-Cu) co-lyophilized in one 70mg vial. It is used to study combined tissue-repair and tissue-remodeling pathways in vitro. Supplied for laboratory research use only.
Blend Composition
- TB-500 · Thymosin β4 Fragment
- 10mg
- BPC-157 · Gastric Pentadecapeptide
- 10mg
- GHK-Cu · Copper Tripeptide
- 50mg
Reference data
GLOW Blend specifications
- Composition
- 10mg TB-500 + 10mg BPC-157 + 50mg GHK-Cu
- Total amount per vial
- 70mg co-lyophilized blend
- Components
- Three research peptides
- Appearance
- White to pale blue lyophilized powder (copper content)
- Solubility
- Soluble in bacteriostatic water
- Purity
- 99.36%
Research applications
Where GLOW Blend is used in research
Areas of study described in the published literature. Listed for research reference only.
Tissue repair
Studied for combined effects of TB-500 and BPC-157 on cell migration and wound healing.
Tissue remodeling
Used in research on GHK-Cu, collagen synthesis, and copper-dependent remodeling pathways.
Angiogenesis
Applied to investigate blood-vessel formation pathways associated with the components.
Combined-pathway designs
Explored in study designs comparing single peptides against a multi-component blend.
Mechanism in research
How GLOW Blend is studied
In published research Thymosin Beta-4 (the parent of TB-500) was reported to support cell migration and angiogenesis, BPC-157 was associated with accelerated tissue healing in animal models, and GHK-Cu was described in tissue-remodeling and wound-repair research. The blend is studied for how these repair and remodeling pathways may act in parallel; combined mechanisms and outcomes in humans are not established.
Reported targets & pathways
- Actin-sequestering / cell-migration pathways (TB-500)
- Angiogenesis and tissue-repair pathways (BPC-157)
- Copper-dependent tissue remodeling (GHK-Cu)
- Collagen and matrix synthesis pathways
Selected research
Published studies on GLOW Blend
Peer-reviewed references for further reading. Findings describe in-vitro and animal research; mechanisms and outcomes in humans are not established.
Frontiers in Pharmacology · 2021
Reviewed preclinical reports in which BPC-157 was associated with accelerated healing across skin, muscle, tendon, and other tissue-injury models in animals.
Annals of the New York Academy of Sciences · 2010
Summarized animal-model studies in which thymosin beta-4 (the parent of TB-500) was reported to support cell migration, angiogenesis, and tissue repair.
Journal of Biomaterials Science, Polymer Edition · 2008
Reviewed the copper-binding tripeptide GHK and its reported roles in tissue-remodeling and wound-repair research.
Comparison
GLOW vs the other research blends
| GLOW | KLOW | BPC-157 + TB-500 | |
|---|---|---|---|
| Components | TB-500, BPC-157, GHK-Cu | TB-500, BPC-157, GHK-Cu, KPV | BPC-157, TB-500 |
| Component count | 3 | 4 | 2 |
| Total per vial | 70mg | 80mg | 10mg / 20mg |
| Added focus | Remodeling (GHK-Cu) | Anti-inflammatory (KPV) | Focused dual repair |
Quality
Independently verified, batch by batch
Tested every batch
Every batch of GLOW Blend is independently analyzed by a third-party laboratory before it is released.
Independently verified
Identity and purity are confirmed by an independent third-party laboratory. This batch is verified to 99.36% purity.
Certificate of analysis
Every batch is independently tested with a certificate of analysis. We send a digital COA with your order.
GLOW Blend FAQ
Shipping GLOW Blend to India?
Free shipping, UPI payments, INR pricing, and same-day dispatch.
Related Products
CJC-1295 + Ipamorelin Blend
99.40% pureResearch blend of CJC-1295 (No DAC) and Ipamorelin, 5mg of each per 10mg vial. A GHRH analogue paired with a selective ghrelin receptor secretagogue for growth hormone pathway and metabolic studies.
KLOW Blend
99.41% pureQuad-peptide research blend of TB-500, BPC-157, GHK-Cu, and KPV, co-lyophilized in a single 80mg vial for combined tissue-repair and anti-inflammatory pathway studies.
BPC-157 + TB-500 Blend
99.28% pureDual-peptide research blend of BPC-157 and TB-500 in a 50/50 split, co-lyophilized for focused tissue-repair and regeneration pathway studies. Available in 10mg and 20mg vials.
